Feasibility and toxicity report from a phase II study of accelerated twice-daily (BDRT) versus high dose once-daily thoracic radiotherapy (ODRT) with concurrent chemotherapy for limited stage small cell lung cancer (LS-SCLC)

C. Faivre-Finn; F. Blackhall; N. Thatcher; P. Taylor; L. Ashcroft; C. Rowbottom; P. Lorigan

doi:10.1200/jco.2008.26.15_suppl.7583

Feasibility and toxicity report from a phase II study of accelerated twice-daily (BDRT) versus high dose once-daily thoracic radiotherapy (ODRT) with concurrent chemotherapy for limited stage small cell lung cancer (LS-SCLC)

C. Faivre-Finn, F. Blackhall, N. Thatcher, P. Taylor, L. Ashcroft, C. Rowbottom, P. Lorigan

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	7583-7583
Number of pages	1
Journal	Journal of Clinical Oncology
Volume	26
Issue number	15_suppl
DOIs	https://doi.org/10.1200/jco.2008.26.15_suppl.7583
Publication status	Published - 24 Feb 2017

Research Beacons, Institutes and Platforms

Manchester Cancer Research Centre

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1200/jco.2008.26.15_suppl.7583

Cite this

Faivre-Finn, C., Blackhall, F., Thatcher, N., Taylor, P., Ashcroft, L., Rowbottom, C., & Lorigan, P. (2017). Feasibility and toxicity report from a phase II study of accelerated twice-daily (BDRT) versus high dose once-daily thoracic radiotherapy (ODRT) with concurrent chemotherapy for limited stage small cell lung cancer (LS-SCLC). Journal of Clinical Oncology, 26(15_suppl), 7583-7583. https://doi.org/10.1200/jco.2008.26.15_suppl.7583

@article{16292501a7e942c986c971ef516e9e64,

title = "Feasibility and toxicity report from a phase II study of accelerated twice-daily (BDRT) versus high dose once-daily thoracic radiotherapy (ODRT) with concurrent chemotherapy for limited stage small cell lung cancer (LS-SCLC)",

author = "C. Faivre-Finn and F. Blackhall and N. Thatcher and P. Taylor and L. Ashcroft and C. Rowbottom and P. Lorigan",

year = "2017",

month = feb,

day = "24",

doi = "10.1200/jco.2008.26.15_suppl.7583",

language = "English",

volume = "26",

pages = "7583--7583",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams & Wilkins",

number = "15_suppl",

}

Faivre-Finn, C , Blackhall, F, Thatcher, N, Taylor, P, Ashcroft, L, Rowbottom, C & Lorigan, P 2017, 'Feasibility and toxicity report from a phase II study of accelerated twice-daily (BDRT) versus high dose once-daily thoracic radiotherapy (ODRT) with concurrent chemotherapy for limited stage small cell lung cancer (LS-SCLC)', Journal of Clinical Oncology, vol. 26, no. 15_suppl, pp. 7583-7583. https://doi.org/10.1200/jco.2008.26.15_suppl.7583

Feasibility and toxicity report from a phase II study of accelerated twice-daily (BDRT) versus high dose once-daily thoracic radiotherapy (ODRT) with concurrent chemotherapy for limited stage small cell lung cancer (LS-SCLC). / Faivre-Finn, C.; Blackhall, F.; Thatcher, N. et al.
In: Journal of Clinical Oncology, Vol. 26, No. 15_suppl, 24.02.2017, p. 7583-7583.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - Feasibility and toxicity report from a phase II study of accelerated twice-daily (BDRT) versus high dose once-daily thoracic radiotherapy (ODRT) with concurrent chemotherapy for limited stage small cell lung cancer (LS-SCLC)

AU - Faivre-Finn, C.

AU - Blackhall, F.

AU - Thatcher, N.

AU - Taylor, P.

AU - Ashcroft, L.

AU - Rowbottom, C.

AU - Lorigan, P.

PY - 2017/2/24

Y1 - 2017/2/24

U2 - 10.1200/jco.2008.26.15_suppl.7583

DO - 10.1200/jco.2008.26.15_suppl.7583

M3 - Meeting Abstract

SN - 0732-183X

VL - 26

SP - 7583

EP - 7583

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 15_suppl

ER -

Faivre-Finn C , Blackhall F, Thatcher N, Taylor P, Ashcroft L, Rowbottom C et al. Feasibility and toxicity report from a phase II study of accelerated twice-daily (BDRT) versus high dose once-daily thoracic radiotherapy (ODRT) with concurrent chemotherapy for limited stage small cell lung cancer (LS-SCLC). Journal of Clinical Oncology. 2017 Feb 24;26(15_suppl):7583-7583. doi: 10.1200/jco.2008.26.15_suppl.7583